Picture of Tempest Therapeutics logo

TPST Tempest Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Tempest Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments62.538.251.831.239.2
Net Total Receivables1.280.314
Prepaid Expenses
Total Other Current Assets
Total Current Assets71.140.9693340.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment3.332.164.1612.710.8
Other Long Term Assets
Total Assets7543.473.246.151.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities12.57.99207.289.41
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities16.410.437.12824.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity58.533.136.118.126.8
Total Liabilities & Shareholders' Equity7543.473.246.151.6
Total Common Shares Outstanding